[Federal Register Volume 65, Number 194 (Thursday, October 5, 2000)]
[Notices]
[Pages 59453-59454]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting;

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Sickle Cell Disease Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such

[[Page 59454]]

as sign language interpretation or other reasonable accommodations, 
should notify the Contact Person listed below in advance of the 
meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: November 13, 2000.
    Time: 8:00 AM to 5:00 PM.
    Agenda: Discussion of program policies and issues.
    Place: National Institutes of Health, Two Rockledge Center, 
Conference Room 9112, 9116, 6701 Rockledge Drive, Bethesda, MD 
20892.
    Contact Person: Charles M Peterson, Director, Blood Diseases 
Program, Division of Blood Diseases and Resources, National Heart, 
Lung, and Blood Institute, NIH, Two Rockledge Center, Room 10158, 
MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435-0050.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)


    Dated: September 27, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-25544 Filed 10-4-00; 8:45 am]
BILLING CODE 4140-01-M